Development and validation of a prediction model for postpartum hemorrhage at a single safety net tertiary care center.

antepartum and intrapartum risk factors cesarean delivery hemorrhage maternal morbidity obstetrical complications prediction of hemorrhage vaginal delivery

Journal

American journal of obstetrics & gynecology MFM
ISSN: 2589-9333
Titre abrégé: Am J Obstet Gynecol MFM
Pays: United States
ID NLM: 101746609

Informations de publication

Date de publication:
09 2021
Historique:
received: 12 05 2021
revised: 19 05 2021
accepted: 20 05 2021
pubmed: 29 5 2021
medline: 18 9 2021
entrez: 28 5 2021
Statut: ppublish

Résumé

Postpartum hemorrhage is a leading cause of pregnancy-related morbidity and mortality; however, there is limited ability to identify women at risk of this obstetrical complication. This study aimed to develop and validate a prediction model for postpartum hemorrhage based on antenatal and intrapartum risk factors. This was a retrospective cohort study of women who delivered between April 2016 and March 2019 at a single safety net hospital. The prevalence of postpartum hemorrhage, defined as blood loss of ≥1000 mL at the time of delivery, was determined, and characteristics were compared between women with and without postpartum hemorrhage. Women were randomly assigned to a prediction or a validation cohort. The selection of predictors to be included in the model was based on known antenatal and intrapartum risk factors for postpartum hemorrhage. A multivariable logistic regression with a backward stepwise approach was used to create a prediction model. Area under the receiver operating characteristic curve and 95% bootstrap confidence intervals were calculated. Using the final model, a single threshold for classifying postpartum hemorrhage was chosen, and the resulting sensitivity, specificity, and false-negative and false-positive rates were explored. The prevalence rates of postpartum hemorrhage in the prediction and validation cohorts were 6.3% (377 of 6000 cases) and 6.4% (241 of 3774 cases), respectively (P=.83). The following predictors were selected for the final model: maternal body mass index (kg/m The model performed reasonably well in identifying women at risk of postpartum hemorrhage. Further studies are necessary to evaluate the model in clinical practice and its effect on decreasing the prevalence of postpartum hemorrhage and associated maternal morbidity.

Sections du résumé

BACKGROUND
Postpartum hemorrhage is a leading cause of pregnancy-related morbidity and mortality; however, there is limited ability to identify women at risk of this obstetrical complication.
OBJECTIVE
This study aimed to develop and validate a prediction model for postpartum hemorrhage based on antenatal and intrapartum risk factors.
STUDY DESIGN
This was a retrospective cohort study of women who delivered between April 2016 and March 2019 at a single safety net hospital. The prevalence of postpartum hemorrhage, defined as blood loss of ≥1000 mL at the time of delivery, was determined, and characteristics were compared between women with and without postpartum hemorrhage. Women were randomly assigned to a prediction or a validation cohort. The selection of predictors to be included in the model was based on known antenatal and intrapartum risk factors for postpartum hemorrhage. A multivariable logistic regression with a backward stepwise approach was used to create a prediction model. Area under the receiver operating characteristic curve and 95% bootstrap confidence intervals were calculated. Using the final model, a single threshold for classifying postpartum hemorrhage was chosen, and the resulting sensitivity, specificity, and false-negative and false-positive rates were explored.
RESULTS
The prevalence rates of postpartum hemorrhage in the prediction and validation cohorts were 6.3% (377 of 6000 cases) and 6.4% (241 of 3774 cases), respectively (P=.83). The following predictors were selected for the final model: maternal body mass index (kg/m
CONCLUSION
The model performed reasonably well in identifying women at risk of postpartum hemorrhage. Further studies are necessary to evaluate the model in clinical practice and its effect on decreasing the prevalence of postpartum hemorrhage and associated maternal morbidity.

Identifiants

pubmed: 34048966
pii: S2589-9333(21)00099-9
doi: 10.1016/j.ajogmf.2021.100404
pii:
doi:

Types de publication

Journal Article Randomized Controlled Trial

Langues

eng

Sous-ensembles de citation

IM

Pagination

100404

Informations de copyright

Copyright © 2021 Elsevier Inc. All rights reserved.

Auteurs

Lindsay Goad (L)

Department of Obstetrics and Gynecology, University of Colorado School of Medicine, Denver, CO (Dr Goad).

Karilynn Rockhill (K)

Rocky Mountain Poison and Drug Safety, Denver, CO (Ms Rockhill and Dr Schwarz).

John Schwarz (J)

Rocky Mountain Poison and Drug Safety, Denver, CO (Ms Rockhill and Dr Schwarz).

Kent Heyborne (K)

Department of Obstetrics and Gynecology, Denver Health Medical Center, University of Colorado School of Medicine, Denver, CO (Drs Heyborne and Fabbri).

Stefka Fabbri (S)

Department of Obstetrics and Gynecology, Denver Health Medical Center, University of Colorado School of Medicine, Denver, CO (Drs Heyborne and Fabbri). Electronic address: Stefka.Fabbri@dhha.org.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH